Friday, October 31, 2014 11:47:51 AM
I've posted many of Dmitry Gabrilovich work on MDSC's and here is just one of them that ties it into Notch Signaling:
----------------
--------------------------------------------------------
Now... I think this is why our KOL's were chosen so carefully. Dmitry is the MD of MDSC's and actually coined the term MDSC's and he has spent his lifes work on researching Myeloid Derived Suppressor Cells and my last post where I seen David Carbone showing up at a "Notch .. conference" back in 2008 in Greece and Dmitry showing up at the world Notch Conference just this past summer... it just becomes clear that Peregrine can't just say Bavi and PS Targeting works, but more importantly why it works. By digging deeper and knowing more about Notch and why a drug works.... well, it looks like they can also start telling why a drug doesn't work and interesting this Roche drug = Erlotinib is said (by Peregrine KOL David Carbone that "dual targeting" may be needed. This seems to hopefully be setting up PS Targeting as that much needed and required target in order to improve Erlotinib and improve just about all over medicines. I think when this was found out way back when.... thats when the goal was not to work with one Big Pharma but get Bavi in the hands of many ( dozens of collaborations ..) and that way, its highly unlikely that one Big Pharma will pay off all other Big Pharmas lol or better yet, all we need is one Big Pharma to seize the opportunity and I believe that one Big Pharma is ready to piggy back along with PS Targeting and stay in business for another hundred years.
------------------------------------------------------
Now, what is important ( in my opinion ) is that Big Pharma just may realize that allowing Bavi to be combined with everything and let current SOC keepers, maintain their SOC's eventually vs allowing Peregrine the (possible) opportunity to actually start dismissing drugs that do not work based on Notch Signaling events.
Time will tell.... but Notch Signaling is certainly on every ones radar and since PS Targeting reduces MDSC's and MDSC's are directly/indirectly related to Notch Signaling, how long will this take to play out before Peregrine reaches $100 per share? I do believe that Peregrine is playing nice because they could just start announcing all this now, but it seems to be playing out slowly for some Big Pharma reason.
Its just a matter of time
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!
Recent CDMO News
- Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance • GlobeNewswire Inc. • 05/23/2024 12:05:46 PM
- Avid Bioservices to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 08:05:11 PM
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:38:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:37:38 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:36:27 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:35:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/11/2024 12:56:02 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/08/2024 09:32:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:56:18 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:55:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:53:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 12:51:57 AM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 12/19/2023 09:05:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 12:34:08 AM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM